RadNetRDNT
RDNT
About: RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
Employees: 10,288
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
66% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 32
22% more funds holding in top 10
Funds holding in top 10: 9 [Q2] → 11 (+2) [Q3]
20% more capital invested
Capital invested by funds: $3.63B [Q2] → $4.35B (+$713M) [Q3]
8% more funds holding
Funds holding: 275 [Q2] → 296 (+21) [Q3]
1.19% more ownership
Funds ownership: 83.51% [Q2] → 84.7% (+1.19%) [Q3]
1% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 100
59% less call options, than puts
Call options by funds: $7.5M | Put options by funds: $18.3M
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$85
17%
upside
Avg. target
$93
28%
upside
High target
$100
38%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
Jefferies Brian Tanquilut 54% 1-year accuracy 7 / 13 met price target | 38%upside $100 | Buy Maintained | 5 Dec 2024 |
Barclays Andrew Mok 29% 1-year accuracy 18 / 62 met price target | 17%upside $85 | Overweight Maintained | 4 Dec 2024 |
Truist Securities David Macdonald 56% 1-year accuracy 49 / 87 met price target | 29%upside $94 | Buy Maintained | 29 Nov 2024 |
Financial journalist opinion
Based on 12 articles about RDNT published over the past 30 days
Neutral
PRNewsWire
2 weeks ago
Ketryx Announces DeepHealth Selected Its Software to Accelerate AI-Powered Health Informatics Innovation
CAMBRIDGE, Mass. , Dec. 4, 2024 /PRNewswire/ -- Ketryx announced today that DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), has selected Ketryx to accelerate the delivery of AI-powered health informatics solutions.
Positive
Investors Business Daily
2 weeks ago
Hunting For Magnificent Growth Next Year? Check Out These 7 Stocks.
None of our picks is Nvidia or Amazon or Tesla. Investors may wish to widen the aperture to find the best stocks for outsize earnings growth.
Positive
Zacks Investment Research
2 weeks ago
RDNT Stock Up Post New Tie-Up to Boost Ultrasound Workflows With AI
RadNet's latest collaboration aims to create an AI-powered SmartTechnology to improve patient experience and operational efficiency in ultrasound.
Positive
Zacks Investment Research
2 weeks ago
RDNT Stock Up Following the New Tie-Up to Leverage Radiology AI
RadNet's latest collaboration aims to create an AI control system for image interpretation to ensure AI scalability, performance monitoring and safety.
Neutral
GlobeNewsWire
2 weeks ago
RadNet, Inc. to Present at the BofA Securities 2024 Leveraged Finance Conference on December 3, 2024
LOS ANGELES, Dec. 02, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the BofA Securities 2024 Leveraged Finance Conference in Boca Raton, FL on Tuesday, December 3, 2024 at 8:10 a.m. Eastern Time (5:10 a.m. Pacific Time).
Neutral
GlobeNewsWire
2 weeks ago
RadNet's Wholly-Owned Subsidiary, DeepHealth, Launches New AI-powered Informatics and SmartTechnology™ Innovations at #RSNA2024
LOS ANGELES and SOMERVILLE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), has launched new AI-powered solutions at RSNA 2024. These solutions enable breakthroughs in imaging-based diagnosis, population health screening programs, and efficient large-scale imaging operations. Moreover, DeepHealth launches SmartTechnology™ solutions that integrate advanced AI and informatics with imaging systems for more efficient, patient-centric workflows. This comprehensive portfolio, anchored on the cloud-native DeepHealth OS, is designed to improve operational efficiency, enhance clinical confidence, while elevating the experiences of patients and care teams. DeepHealth has established strategic collaborations with industry leaders in healthcare, medical imaging, AI, and cloud platforms to continuously innovate solutions, business models, and new care paradigms with the aim of empowering breakthroughs in care by unlocking the value of imaging.
Neutral
GlobeNewsWire
2 weeks ago
Siemens Healthineers and RadNet's Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™
LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) -- Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today announced a strategic collaboration aimed at transforming ultrasound operations through the implementation of SmartTechnology™ by embedding AI-powered health informatics within workflows and imaging hardware. The collaboration will combine Siemens Healthineers' Acuson Sequoia ultrasound system, RadNet's expertise in high-volume outpatient care, and DeepHealth's SmartSonography™ solution powered by the cloud-native DeepHealth OS to tackle workflow and workforce challenges for enhanced operational efficiency and better patient experience.
Neutral
Business Wire
2 weeks ago
Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet
WILMINGTON, Del.--(BUSINESS WIRE)--Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet.
Neutral
GlobeNewsWire
2 weeks ago
RadNet's Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai's Platform to Develop a New AI Control System for Clinical AI Performance and Safety
LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced a strategic collaboration with CARPL.ai, a leading AI orchestration company that enables radiologists to access, assess, and integrate radiology AI solutions in their workflows. DeepHealth will use CARPL.ai's technology to develop an AI control system that can be commercialized and will be designed to monitor and optimize imaging AI performance for improved clinical outcomes, operational efficiency, and accelerated adoption of AI in radiology. AI monitoring is crucial to ensure reliable, accurate, and unbiased performance.
Neutral
GlobeNewsWire
3 weeks ago
CORRECTION: RadNet's DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
SOMERVILLE, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Friday, November 29th by RadNet, Inc. (NASDAQ: RDNT), please note that in the third sentence of the first paragraph, the year that SmartMammo Dx was first cleared should be 2021, not 2012. The corrected release follows:
Charts implemented using Lightweight Charts™